Transsphenoidal Extent of Resection Study
NCT02357498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260
Last updated 2019-11-25
Summary
The purpose of this research study is to compare the extent of resection (EOR) in patients with nonfunctioning pituitary adenomas undergoing transsphenoidal surgery using a microsurgical technique to those patients who have undergone surgery with a fully endoscopic technique. Another goal is to compare surgical complications, endocrine outcomes, visual outcomes, length of surgery, length of hospital stay, and readmission rates between the two transsphenoidal surgery techniques. This is an observational data collection study with no experimental procedures or experimental medicines. Endonasal transsphenoidal removal of a pituitary tumor is a unique procedure and there is little information comparing the two surgical techniques.
Conditions
- Pituitary Adenoma
Interventions
- PROCEDURE
-
transsphenoidal surgery
Sponsors & Collaborators
-
Saint John's Cancer Institute
collaborator OTHER -
Swedish Medical Center
collaborator OTHER - collaborator OTHER
-
Ohio State University
collaborator OTHER -
Washington University School of Medicine
collaborator OTHER -
University of Pittsburgh Medical Center
collaborator OTHER -
St. Joseph's Hospital and Medical Center, Phoenix
lead OTHER
Principal Investigators
-
Andrew Little, MD · Saint Joseph's Hospital and Medical Center/Barrow Neurological Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-01
- Primary Completion
- 2019-02-01
- Completion
- 2019-04-08
Countries
- United States
Study Locations
More Related Trials
-
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 ·Status: UNKNOWN
-
Surgical Debulking of Pituitary Adenomas
NCT01371643 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED
-
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
NCT01861717 ·Status: TERMINATED ·Phase: PHASE4
-
Preoperative Octreotide Treatment of Acromegaly
NCT00521300 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma
NCT03284775 ·Status: COMPLETED ·Phase: NA
-
Cabergoline in Nonfunctioning Pituitary Adenomas
NCT03271918 ·Status: COMPLETED ·Phase: PHASE3
-
Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery
NCT04584866 ·Status: COMPLETED ·Phase: NA
-
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
NCT06435195 ·Status: RECRUITING
-
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
NCT02288962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
NCT02190994 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
NCT01794793 ·Status: COMPLETED ·Phase: PHASE4
-
Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery
NCT05149495 ·Status: UNKNOWN
-
Multicentric Prospective Validation of the Zurich Pituitary Score
NCT04076046 ·Status: COMPLETED
-
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
NCT00647179 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
NCT01283542 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
NCT03439709 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
NCT00225979 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study of Outcome After Therapy for Acromegaly
NCT01809808 ·Status: COMPLETED
-
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
NCT06679816 ·Status: RECRUITING ·Phase: PHASE4